230 related articles for article (PubMed ID: 27389672)
1. Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States.
Maust DT; Bonar EE; Ilgen MA; Blow FC; Kales HC
Am J Geriatr Psychiatry; 2016 Nov; 24(11):1000-1003. PubMed ID: 27389672
[TBL] [Abstract][Full Text] [Related]
2. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.
Shover CL; Vest NA; Chen D; Stueber A; Falasinnu TO; Hah JM; Kim J; Mackey I; Weber KA; Ziadni M; Humphreys K
JAMA Netw Open; 2020 Jul; 3(7):e2010001. PubMed ID: 32662844
[TBL] [Abstract][Full Text] [Related]
3. Medical marijuana: Legal and regulatory considerations.
Kaplan L
Nurse Pract; 2015 Oct; 40(10):46-54; quiz 54-5. PubMed ID: 26383024
[TBL] [Abstract][Full Text] [Related]
4. Medical marijuana: Legal considerations for physicians.
Martin J
Med Econ; 2015 Dec; 92(23):43-4. PubMed ID: 26875333
[No Abstract] [Full Text] [Related]
5. Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017.
Klieger SB; Gutman A; Allen L; Pacula RL; Ibrahim JK; Burris S
Addiction; 2017 Dec; 112(12):2206-2216. PubMed ID: 28696583
[TBL] [Abstract][Full Text] [Related]
6. An Ethical Framework to Manage Patient Requests for Medical Marijuana.
Redinger M; Fledderman N; Crutchfield P
J Am Board Fam Med; 2020; 33(1):147-151. PubMed ID: 31907257
[TBL] [Abstract][Full Text] [Related]
7. U.S. Policy Responses to Calls for the Medical Use of Cannabis.
Hall W
Yale J Biol Med; 2015 Sep; 88(3):257-64. PubMed ID: 26339208
[TBL] [Abstract][Full Text] [Related]
8. [Cannabis politics - but truthful].
Kappert-Gonther K
MMW Fortschr Med; 2016 May; 158(10):40. PubMed ID: 27221425
[No Abstract] [Full Text] [Related]
9. Medical Marijuana.
Capriotti T
Home Healthc Now; 2016 Jan; 34(1):10-5. PubMed ID: 26645838
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
[TBL] [Abstract][Full Text] [Related]
11. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
Stahl SM
CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
[TBL] [Abstract][Full Text] [Related]
12. The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.
Ryan J; Sharts-Hopko N
J Neurosci Nurs; 2017 Jun; 49(3):185-190. PubMed ID: 28471927
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine treatment of agitation associated with dementia.
Leibovici A; Tariot PN
J Geriatr Psychiatry Neurol; 1988; 1(2):110-2. PubMed ID: 3252879
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R; Cummings J; Raman R; Thal L;
Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
[TBL] [Abstract][Full Text] [Related]
15. (Re)introducing medicinal cannabis.
Mather LE; Rauwendaal ER; Moxham-Hall VL; Wodak AD
Med J Aust; 2013 Dec; 199(11):759-61. PubMed ID: 24329652
[TBL] [Abstract][Full Text] [Related]
16. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
Devanand DP; Pelton GH; D'Antonio K; Strickler JG; Kreisl WC; Noble J; Marder K; Skomorowsky A; Huey ED
Alzheimer Dis Assoc Disord; 2017; 31(1):73-75. PubMed ID: 27819842
[No Abstract] [Full Text] [Related]
17. Dispensaries: the Wild West of Vancouver.
Lough S
CMAJ; 2015 Aug; 187(11):E345-E346. PubMed ID: 26195580
[No Abstract] [Full Text] [Related]
18. The Impact of Legalizing and Regulating Weed: Issues with Study Design and Emerging Findings in the USA.
Hunt PE; Miles J
Curr Top Behav Neurosci; 2017; 34():173-198. PubMed ID: 26718590
[TBL] [Abstract][Full Text] [Related]
19. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
20. Treatment of agitation in older persons with dementia. The Expert Concensus Panel for agitation in dementia.
Postgrad Med; 1998 Apr; Spec No():1-88. PubMed ID: 9585819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
